Does the constipation from Mounjaro go away — and how long does it take?

The first few weeks: why constipation shows up at all

Picture this: you have just started Mounjaro, or you have just moved up to a higher dose. The nausea most people expect is there, but so is something you perhaps did not anticipate, your gut is moving more slowly than it used to. Tirzepatide slows gastric emptying as part of its mechanism, and that slowdown does not stop at the stomach. Food and waste move through the entire digestive tract at a reduced pace, which means stools can become harder and less frequent. If you are wondering whether Mounjaro causes constipation and why the body responds this way, the short answer is that it is the medicine doing what it is designed to do, not a sign that anything has gone wrong.

In the first two to four weeks at a new dose, this effect tends to be at its most noticeable. The gut has not yet adapted to tirzepatide's influence on smooth muscle activity. Most people find that after that adjustment window, gut habits begin to normalise, not necessarily to exactly what they were before, but to a manageable rhythm. Drinking enough water is the single most practical thing you can do during this period, because reduced appetite also tends to mean reduced fluid intake, which compounds the problem. Our detailed page on managing constipation on Mounjaro covers practical strategies in full.

It is also worth knowing that eating less, particularly if your intake of fibre-rich foods has dropped alongside appetite, removes some of the bulk that keeps stools soft and regular. Focusing on vegetables, pulses and wholegrains (even in smaller portions) makes a real difference to how quickly this side effect settles.

Does it go away completely, or does it come back with each dose step?

For many people, yes, it eases substantially once the body settles at a given dose. The difficulty is the titration schedule: Mounjaro starts at 2.5 mg and is stepped upward by the prescriber, typically in four-week intervals. Each step can restart the adjustment process, so constipation that seemed to resolve at 2.5 mg may reappear briefly when moving to 5 mg, and so on. This is not a sign the medicine is not working; it is the gut recalibrating again.

Knowing this pattern in advance helps. If you are approaching a dose change (perhaps it is landing around a bank holiday weekend, or you are heading into a busy stretch and want to plan ahead) it is worth building good hydration and fibre habits the week before, rather than waiting to feel uncomfortable first. Some people find the higher dose steps settle more quickly, possibly because the gut has already partially adapted to tirzepatide's action.

People who find constipation persists beyond four to six weeks at a stable dose should raise it with their prescriber rather than self-managing indefinitely. There are practical interventions, and in some cases the prescriber may consider whether the titration pace needs to be adjusted. Our page on stopping constipation on Mounjaro outlines the lifestyle and clinical options your team may discuss.

Constipation versus diarrhoea: Mounjaro can cause both

It might seem contradictory, but tirzepatide is associated with both constipation and diarrhoea, sometimes in the same person at different points in treatment. Diarrhoea tends to appear earlier or more acutely, often in the immediate days after an injection, while constipation more commonly settles in as a background pattern. Some people cycle between the two as the gut adjusts. If you are experiencing loose stools as well as periods of difficulty passing them, you are not imagining a contradiction. Our page on whether Mounjaro diarrhoea goes away covers the other side of this picture.

Both effects sit under the umbrella of gastrointestinal side effects listed in the Mounjaro patient information leaflet. The electronic Medicines Compendium holds the full Summary of Product Characteristics, which lists the frequency and nature of reported GI effects in the clinical trial programme. Reading it before your first injection (or before a dose step) gives a clearer picture of what the evidence says, and what to flag to your prescriber. A broader overview of what to watch for is on our Mounjaro side effects page.

When constipation needs urgent attention, not just patience

Most constipation on Mounjaro is uncomfortable, not dangerous. But there are symptoms that cross a line and need prompt medical assessment, not a wait-and-see approach. Seek help the same day (or call 999 if severe) for any of the following: persistent abdominal pain that does not ease and radiates toward your back, signs of serious dehydration (extreme thirst, very dark urine, dizziness when standing), complete inability to pass wind or stools for several days alongside a distended or rigid abdomen, or blood in your stools.

The MHRA's January 2026 Drug Safety Update for GLP-1 medicines highlighted acute pancreatitis as an infrequent but serious risk: the characteristic symptom is intense, unrelenting stomach pain that spreads to the back, sometimes with vomiting. This is distinct from ordinary constipation, but the overlap in location means it must not be dismissed. If you are ever unsure, act on the side of caution and contact your GP, call 111, or go to an emergency department. You can also report any suspected side effect, including one you are unsure about, through the MHRA's Yellow Card scheme, your report contributes to the ongoing safety monitoring of this medicine.

At nume, our prescribers discuss side effects (including this one) as part of every consultation, and they are available for aftercare questions seven days a week. If you are considering starting treatment or transferring from another provider, a free consultation with our clinical team is the starting point. You can also read more about how tirzepatide works and what to expect on our main Mounjaro information page.